Abstract:Xiaomei Jiang, 1, &ast Xiaohong Jiang, 2, &ast Dongjie Wu, 1 Wanzhu Xie, 3 Xiong Liu, 1 Jintao Zheng 4 1 Department of Dermatology, Liuzhou Traditional Chinese Medicine Hospital, Liuzhou, 545001, People's Republic of China; 2 Department of Pharmacy, Shantou University Medical College, Shantou, 515041, People's Republic of China; 3 Department of Rehabilitation, Liuzhou Worker's Hospital, Liuzhou, 545001, People's Republic of China; 4 Department of Biotechnology and Food Engineering, Guangdong Technology Israel Institute of Technology, Shantou, 515063, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jintao Zheng, Department of Biotechnology and Food Engineering, Guangdong Technology Israel Institute of Technology, Shantou, 515063, People's Republic of China, Tel +86 156 2584 9047, Email Background: Radiotherapy is a widely used clinical tool for tumor treatment but can cause systemic toxicity if excessive radiation is administered. Although numerous nanoparticles have been developed as radiosensitizers to reduce the required dose of X-ray irradiation, they often have limitations, such as passive reliance on radiation-induced apoptosis in tumors, and little consider the unique tumor microenvironment that contributes radiotherapy resistance. Methods: In this study, we developed and characterized a novel self-assembled nanoparticle containing dysprosium ion and manganese ion (Dy/Mn-P). We systematically investigated the potential of Dy/Mn-P nanoparticles (NPs) as a reactive oxygen species (ROS) amplifier and radiosensitizer to enhance radiation therapy and modulate the tumor microenvironment at the cellular level. Additionally, we evaluated the effect of Dy/Mn-P on the stimulator of interferon genes (STING), an innate immune signaling pathway. Results: Physicochemical analysis demonstrated the prepared Dy/Mn-P NPs exhibited excellent dispersibility and stability, and degraded rapidly at lower pH values. Furthermore, Dy/Mn-P was internalized by cells and exhibited selective toxicity towards tumor cells compared to normal cells. Our findings also revealed that Dy/Mn-P NPs improved the tumor microenvironment and significantly increased ROS generation under ionizing radiation, resulting in a ~70% increase in ROS levels compared to radiation therapy alone. This enhanced ROS generation inhibited ~92% of cell clone formation and greatly contributed to cytoplasmic DNA exposure. Subsequently, the activation of the STING pathway was observed, leading to the secretion of pro-inflammatory immune factors and maturation of dendritic cells (DCs). Conclusion: Our study demonstrates that Dy/Mn-P NPs can potentiate tumor radiotherapy by improving the tumor microenvironment and increasing endogenous ROS levels within the tumor. Furthermore, Dy/Mn-P can amplify the activation of the STING pathway during radiotherapy, thereby triggering an anti-tumor immune response. This novel approach has the potential to expand the application of radiotherapy in tumor treatment. Keywords: radiotherapy, Dy/Mn-P NPs, ROS, tumor microenvironment, STING pathway Radiotherapy (RT) is a widely used method for treating cancer in contemporary clinical practice. Regrettably, despite its unparalleled curative efficacy, the therapeutic potential of this method is hindered by unfavorable adverse effects, most notably the health hazards associated with excessive radiation doses. 1,2 Recently, the use of NPs based on metal atoms with high atomic numbers in combination with radiation therapy to enhance the effect of radiation by accumulating or releasing more in the tumor site compared to healthy tissues can effectively increase the efficiency of radiotherapy and reduce side effects. 3–5 For instance, hafnium (Hf), gold (Au), and lanthanide elements have been developed as novel radio-sensitizing nanoparticles to effectively capture more local radiation dose inside the tumor since they possess a high atomic number, thus reducing the side effects of radiation therapy. 6–12 During the RT, these radiosensitizers can interact with X-ray via several physical processes, releasing electrons and generating ROS, leading to irreparable DNA lesions and inducing tumor cell apoptosis. 13–16 However, the unique tumor microenvironment (TME) poses challenges to the effectiveness of radiation therapy. For instance, the high levels of glutathione (GSH) and hydrogen peroxide (H 2 O 2 ) within the tumor create an environment that hampers the efficacy of radiotherapy and promotes resistance to treatment. 17–20 Additionally, a lack of tumor sensiti -Abstract Truncated-

Sensitization of proton therapy and deuteron therapy by using

[Proposal and Analysis of "Ternary" Model of Sensitization for Proton Therapy]

Enhancing Proton Therapy Efficacy Through Nanoparticle-Mediated Radiosensitization

A ternary model of proton therapy based on boron medium radiosensitization and enhancement paths: a Monte Carlo simulation

Application of proton boron fusion reaction to radiation therapy: A Monte Carlo simulation study

Boron Nanoparticle-Enhanced Proton Therapy: Molecular Mechanisms of Tumor Cell Sensitization

Enabling Clinical Use of Linear Energy Transfer in Proton Therapy for Head and Neck Cancer -- A Review of Implications for Treatment Planning and Adverse Events Study

Biological optimization for hybrid proton-photon radiotherapy

Proton and heavy ion radiotherapy: the context and challenges

Nuclear fusion enhances cancer cell killing efficacy in a protontherapy model

Proton-CAT: a Novel Strategy for Enhanced Proton Therapy

Particle Therapy for Cancers: a New Weapon in Radiation Therapy.

Application of nanomedicine in radiotherapy sensitization

Aspects of the physical principles of the proton therapy with inclusion of nuclear interactions

Microdosimetric Evaluation on the Metallic Nanoparticle-Mediated Dose Enhancement in Radiotherapeutic Proton Irradiation

Radiosensitization with metallic nanoparticles under MeV proton beams: local dose enhancement

Amplifying Radiotherapy by Evoking Mitochondrial Oxidative Stress Using a High-performance Aggregation-induced Emission Sonosensitizer

Optimization of Combined Electron and Photon Beams for Breast Cancer

The Proton-Boron Reaction Increases the Radiobiological Effectiveness of Clinical Low- and High-Energy Proton Beams: Novel Experimental Evidence and Perspectives

Proton Improves BED&nbsp;Compared With Photon Beam-based Partial Stereotactic Ablative Boost Radiotherapy for Large Non-small Cell Lung Cancer

A pH-Sensitive Nanoparticle as Reactive Oxygen Species Amplifier to Regulate Tumor Microenvironment and Potentiate Tumor Radiotherapy